Inpatient Antibiotic Costs Associated With Switching From Vancomycin to Daptomycin for Outpatient Parenteral Antibiotic Therapy.

Beardsley, James; Patel, Swetangini; Cook, Corbin; Pierce, Brandi; Johnson, James; Ohl, Christopher; Luther, Vera

Beardsley, James; Patel, Swetangini; Cook, Corbin; Pierce, Brandi; Johnson, James; Ohl, Christopher; Luther, Vera.

Afiliação

Beardsley J; Wake Forest Baptist Health, Winston-Salem, NC, USA.
Patel S; Wake Forest School of Medicine, Winston-Salem, NC, USA.
Cook C; Wingate University School of Pharmacy, Wingate, NC, USA.
Pierce B; Wingate University School of Pharmacy, Wingate, NC, USA.
Johnson J; Wingate University School of Pharmacy, Wingate, NC, USA.
Ohl C; Wake Forest Baptist Health, Winston-Salem, NC, USA.
Luther V; Wake Forest School of Medicine, Winston-Salem, NC, USA.

Hosp Pharm ; 57(1): 17-19, 2022 Feb.

Article em En | MEDLINE | ID: mdl-35521017

Palavras-chave

OPAT; daptomycin; outpatient parenteral antibiotic therapy; pharmacy expenditures

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Risk_factors_studies Idioma: En Revista: Hosp Pharm Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google